Indefinite Delivery Contract SPE2DR25D3103

Award Date 11/13/25
Last Date to Order 12/31/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $9,999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The contract aims to establish Prime Vendor Contracts for the...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract, valued at up to $999,999,999, has a 30-month base period and three 30-month option periods, for a total potential performance period through November 2026. The contract aims to establish Prime Vendor...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. The contract covers a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion. The IDC aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which will...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods. The contract aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to support the Defense Health Agency (DHA),...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single, unrestricted Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a base period of 30 months and three 30-month option periods, with an estimated total value of $30.3 billion across all regions. This IDC serves as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract, providing...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The $999,999,999 IDC has a 30-month base period and three 30-month option periods, totaling a potential 10-year period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for the...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract, valued at $9,999,999,999, has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The contract aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. This contract, referred to as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), covers a broad range of pharmaceutical and medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical and medical supply support to various DoD customers. The IDC covers a 30-month base period with three 30-month option periods, for a total period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through December 2036, is an unrestricted, fully competitive acquisition to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The purpose of the PPV-G GEN V program is to...

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The IDC covers a 30-month base period with three 30-month option periods, totaling an estimated $30.3 billion in value across multiple regional contracts.

This IDC, known as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish Prime Vendor Contracts to support normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness (PVR), and War Readiness Materiel (WRM) for the Defense Health Agency (DHA), DoD, United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet. The contracted products include brand, generic, and specialty pharmaceuticals, as well as pharmaceutical-related supplies, to be delivered to CONUS and OCONUS locations. The solicitation is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation criteria, with the potential for a reverse auction to determine final distribution fees.

Generated 6/6/25, 10:09 AM